Asia / TAIWAN
Company Overview
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and new drug development. Its production line includes various core technologies required by the cell therapy industry to provide CMO (contracted production services) and CDMO (commissioned development and manufacturing services) and testing services. The company was founded by Cheng Han Wen on June 12, 2019 and is headquartered in Taoyuan, Taiwan.
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and new drug development. Its production line includes various core technologies required by the cell therapy industry to provide CMO (contracted production services) and CDMO (commissioned development and manufacturing services) and testing services. The company was founded by Cheng Han Wen on June 12, 2019 and is headquartered in Taoyuan, Taiwan.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Biological Products Exc. Diagnostic |
| Country | TAIWAN |
| Employees | 53 |
| Reporting Unit | Billions |
| Primary Exchange | Unknown exchange |
| Instrument Type | Equity |
| Wright ID | C158R5D0T |
Key Metrics
| Current price | $43.30 |
| Market cap | $2.26 B |
| P/E ratio | 17.19 |
| 52-week perf. | -24.1% |
| Common shares | 52.1 M |
| Share type | Gu |
| Quality rating | LAC10 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | 0.0% |
| 4 Week | -1.6% |
| 13 Week | -2.3% |
Officers
n/a
Address
TAIWAN
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.